VIA DERMIS Trademark

Trademark Overview

On Tuesday, April 27, 2021, a trademark application was filed for VIA DERMIS with the United States Patent and Trademark Office. The USPTO has given the VIA DERMIS trademark a serial number of 90674635. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Sunday, September 8, 2024. This trademark is owned by Vivex Biologics Group, Inc.. The VIA DERMIS trademark is filed in the Pharmaceutical Products category with the following description:

Biological dermal tissue intended for subsequent implantation
via dermis

General Information

Serial Number90674635
Word MarkVIA DERMIS
Filing DateTuesday, April 27, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateSunday, September 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 11, 2022

Trademark Statements

Goods and ServicesBiological dermal tissue intended for subsequent implantation
NOT AVAILABLE"DERMIS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVivex Biologics Group, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339
Party NameVivex Biologics Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339

Trademark Events

Event DateEvent Description
Friday, April 30, 2021NEW APPLICATION ENTERED
Monday, December 6, 2021ASSIGNED TO EXAMINER
Wednesday, December 8, 2021EXAMINERS AMENDMENT E-MAILED
Monday, August 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 8, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 8, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, December 8, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 22, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 11, 2022PUBLISHED FOR OPPOSITION
Wednesday, December 8, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 8, 2022SOU EXTENSION 1 FILED
Monday, October 10, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, October 12, 2022PETITION TO REVIVE-GRANTED
Wednesday, October 12, 2022TEAS PETITION TO REVIVE RECEIVED
Wednesday, October 12, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, October 12, 2022NOTICE OF REVIVAL - E-MAILED
Tuesday, November 15, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 15, 2022SOU EXTENSION 1 GRANTED
Wednesday, November 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 3, 2023SOU EXTENSION 2 FILED
Friday, March 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 3, 2023SOU EXTENSION 2 GRANTED
Saturday, September 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 5, 2024SOU EXTENSION 4 GRANTED
Tuesday, March 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 7, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 7, 2023SOU EXTENSION 3 FILED
Thursday, September 7, 2023SOU EXTENSION 3 GRANTED
Monday, February 5, 2024SOU TEAS EXTENSION RECEIVED
Monday, February 5, 2024SOU EXTENSION 4 FILED
Wednesday, February 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 8, 2024SOU TEAS EXTENSION RECEIVED
Sunday, September 8, 2024SOU EXTENSION 5 GRANTED
Sunday, September 8, 2024SOU EXTENSION 5 FILED

Related Keywords

dermis subsequent implantation intended tissue dermal biological